US9611224, Example 14;(2S)-N-[(3S)-1-[[2-[2-(3-hydroxyoxetan-3-yl)ethynyl]naphthalen-1-yl]methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-2-(methylamino)propanamide
Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R
1
, R
2
, R
3
and R
4
are described in this application, and methods of using said compounds in the treatment of cancer.